Clin2
NCT06847399Possibly a fitRecruiting

Tirzepatide for Binge Eating Disorder

Obesity and OverweightBinge Eating Disorder

Treatments studied

Part of Hormones & metabolism, Mental health clinical trials.

This trial tests if tirzepatide (a weekly injection) can help reduce binge eating compared to a placebo or another medication (lisdexamfetamine dimesylate). It may be a good fit for people with moderate or severe binge eating disorder who also have a high body weight.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
105 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have binge eating disorder with at least 4 binge episodes per week.
  • Your body mass index (BMI) is 30 or higher, or 27 or higher with a weight-related health problem like high blood pressure.
  • You have tried to lose weight with dieting before but it hasn't worked.
  • You are willing to learn to give yourself a weekly injection and take daily capsules.
  • You do not have diabetes, bulimia, anorexia, or certain other medical conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06994338Recruiting· Phase 2
Tirzepatide for alcohol use disorder

This study tests whether a medication called tirzepatide (a once-weekly injection) can help people reduce their alcohol consumption. It is for people who drink heavily, have a high BMI, and are actively seeking help to drink less.

Los Angeles, California
NCT07693608Enrolling by invitation· Phase 2
Tirzepatide for weight loss in stimulant use disorder

This trial tests whether a weekly injection called tirzepatide (a diabetes and weight-loss medication) can help people with obesity and stimulant use disorder reduce stimulant use and lose weight. It aims to see if treating both conditions together improves outcomes.

Dallas, Texas
NCT06439277Recruiting· Phase 3
Tirzepatide for teens with obesity and related health problems

This study tests a medication called tirzepatide (a once-weekly injection) to help teenagers with obesity and related health conditions lose weight. It aims to see if the drug is safe and effective for this age group.

Los Angeles, California
NCT07504172Not yet recruiting
Tirzepatide for weight loss in people with obesity

This trial looks at whether a medicine called tirzepatide (given as an injection) helps people with obesity lose weight in real life. Researchers will also see how people use the medicine, which may help doctors find better ways to treat obesity.

Amsterdam
NCT07099742Not yet recruiting
Tirzepatide for weight loss in adults with obesity

This study tests a medicine called tirzepatide to see if it helps people with overweight or obesity lose weight, whether or not they also have type 2 diabetes. Tirzepatide is given as an injection and works on hormones that control appetite.

Comilla
NCT07829198Not yet recruiting· Phase 3
Tirzepatide for weight loss after prior bariatric surgery

This study tests a medication called tirzepatide (a daily injection) to help people who haven't lost enough weight after weight-loss surgery. If you fit the criteria, the medication may help you lose more weight healthily.

Porto

Hear when a new Binge-Eating Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.